Industry News

Coding and Billing for Adult Vaccinations

07/13/17

In May, the National Adult and Influenza Immunization Summit posted Coding and Billing for Adult Vaccinations on its website. A summary from the web section is reprinted below.

A common problem that has been expressed by providers of adult vaccinations has been the intricacies and complexities associated with coding and billing for those services. Much discussion at meetings of the National Adult and Influenza Immunization Summit (“Summit”) has focused on opportunities to provide information to providers to reduce the errors and confusion associated with coding and billing for adult vaccines. The Summit’s Access and Provider Workgroup has developed this website in response to this identified need.

Acquired from http://www.immunize.org/express/issue1315.asp on 7/13/17. We thank the Immunization Action Coalition.


Provider Resources for Vaccine Conversations with Parents

06/09/17

Many parents have questions about their children’s vaccines, and answering their questions can help parents feel confident in choosing to immunize their child according to the CDC’s recommended immunization schedule. CDC, The American Academy of Pediatrics (AAP), and The American Academy of Family Physicians (AAFP) created Provider Resources for Vaccine Conversations with Parents to help healthcare professionals assess parents’ needs, identify the role they want to play in making decisions for their child’s health, and then communicate in ways that meet their needs.

These resources are intended to help health care professionals start or continue conversations with parents. They include proven communication strategies and tips for effectively addressing questions from parents, fact sheets on vaccine-preventable diseases and vaccine safety, as well as information for parents who choose not to vaccinate. There is also a video featuring a CDC pediatrician answering tough vaccine questions and much more.

These Provider Resources are based on formative research, informed by risk communication principles, and reviewed extensively by subject matter experts.

Read Original Article on CDC Website


So far in 2017, 42 states and D.C. have reported 1,965 mumps cases; learn more

04/19/17

From January 1 to March 25, 2017, 42 U.S. states and the District of Columbia reported 1,965 mumps cases to CDC. Some information from CDC’s website follows.

Mumps is no longer very common in the United States. From year to year, mumps cases can range from roughly a couple hundred to a couple thousand. For example in 2016, there were approximately 5,748 cases reported to CDC, and in 2012, there were 229. Before the U.S. mumps vaccination program started in 1967, about 186,000 cases were reported each year, but the actual number of cases was likely much higher due to underreporting. Since the pre-vaccine era, there has been a more than 99% decrease in mumps cases in the United States….

In some years, there are more cases of mumps than usual because of outbreaks. Mumps outbreaks can occur any time of year. A major factor contributing to outbreaks is being in a crowded environment, such as attending the same class, playing on the same sports team, or living in a dormitory with a person who has mumps. Also, certain behaviors that result in exchanging saliva, such as kissing or sharing utensils, cups, lipstick or cigarettes, might increase spread of the virus.

MMR vaccine prevents most, but not all, cases of mumps and complications caused by the disease. Two doses of the vaccine are 88% (range: 66 to 95%) effective at protecting against mumps; one dose is 78% (range: 49% to 92%) effective. The MMR vaccine protects against currently circulating mumps strains. Outbreaks can still occur in highly vaccinated U.S. communities, particularly in close-contact settings. In recent years, outbreaks have occurred in schools, colleges, and camps. However, high vaccination coverage helps limit the size, duration, and spread of mumps outbreaks.

Related Links

This article is reprinted from original material provided by the Immunization Action Coalition. Content may be viewed in its original context by clicking here.


Popular slide deck for healthcare professionals on meningococcal disease prevention and how to increase second dose coverage

04/06/17

In 2015, IAC launched MCV4: You’re Not Done If You Give Just One; Give 2 Doses to Strengthen Protection, in collaboration with Sanofi Pasteur. This project was developed in response to the low immunization rates found for the recommended second (booster) dose of meningococcal ACWY (MCV4) vaccine.

As part of this project, a downloadable slide deck (with accompanying speaker notes) was added to the www.Give2MCV4.org website in 2016. This valuable resource was made available for use by healthcare professionals (HCPs) to assist them in educating HCPs about the seriousness of meningococcal disease and the risk it poses to adolescents, raise awareness of the low immunization rates for the second (booster) dose of MCV4, and offer tools and resources to help HCPs increase their immunization rates and close the meningococcal booster dose gap.

This popular slide deck was just updated to include more recent data, as well as to incorporate recently revised recommendations for HPV and meningococcal group B vaccine. The new 16-year-old immunization platform highlighted in the ACIP’s recommended immunization schedule is also mentioned in the Speaker’s Notes.

This “ready-to-use” slide deck, which may be used free of charge, is available in two convenient formats.

  • PDF version of the slides (without speaker notes)
  • PowerPoint version, which can be downloaded and used for presentations to HCPs. The slide deck may be viewed with the embedded speaker notes. (Be sure to read the “Important Notes” on the download page for assistance in how to view the speaker notes.)

To access the slide deck in either format, go to www.give2mcv4.org/essential-tools/slide-deck. Be sure to take advantage of this great training tool and the wealth of other educational resources available on the website.

Related Links

This article is reprinted from original material provided by the Immunization Action Coalition. Content may be viewed in its original context by clicking here.